INFINITY PHARMACEUTICALS INC (INFI)

US45665G3039 - Common Stock

0.0447  -0.04 (-46.98%)

After market: 0.04 0 (-10.51%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
2.57M2.59M1.86M1.70M3.00M
Cost Of Goods
1.55M1.56M1.12M1.00M7.30M
Gross Profit
1.02M1.03M738.00K700.00K-4.30M
Operating Expenses
43.07M45.87M45.82M39.20M41.40M
Research and Development
27.08M32.41M31.65M26.80M27.10M
Selling, General, and Administrative Expenses
15.99M13.46M14.17M12.40M14.30M
Operating Income
-42.05M-44.84M-45.08M-38.50M-45.70M
Interest Income/Expense
1.10M475.00K-179.00K-2.00M-1.40M
Other Income/Expense
N/AN/AN/AN/AN/A
Income Before Taxes
-40.95M-44.37M-45.26M-40.50M-47.10M
Income Tax
N/AN/AN/A0.00-100.00K
Net Income
-40.95M-44.37M-45.26M-40.50M-47.10M
EBITDA
-41.62M-44.39M-44.60M-38.00M-45.50M
 
Per Share Data
EPS Diluted Total Ops
-0.46-0.50-0.53-0.68-0.83
Non GAAP EPS
N/A-0.50-0.53-0.67-0.82
 
Statistics
Gross Profit Margin
39.70%39.72%39.72%41.18%-143.33%
Profit Margin
-1593.93%-1711.11%-2436.06%-2382.35%-1570.00%
Operating Profit Margin
-1636.67%-1729.43%-2426.43%-2264.71%-1523.33%

All data in USD

Charts